In addition to IGF-1, estrogen is critical in breast cancer, and adiponectin is receiving increasing attention in pancreatic cancer; leptin and adiponectin have been relatively less studied in endocrine-related cancers. This evidence concerns the gene LEP and breast carcinoma.